Agios to Participate in March Investor Conferences

CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering...

German American Bank announces Michael F. Beckwith as Chief

JASPER, Ind., March 02, 2023 (GLOBE NEWSWIRE) -- German American Bancorp, Inc. (NASDAQ: GABC) and its banking subsidiary, German American Bank, announces...

Aerovate Therapeutics to Present at Cowen 43rd Annual

WALTHAM, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on...

Homology Medicines to Participate in the 43rd Annual Cowen

BEDFORD, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Albert...

Medicenna to Present at the Oppenheimer 33rd Annual

TORONTO and HOUSTON, March 02, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a...

Pharvaris to Present in Upcoming March Investor

ZUG, Switzerland, March 02, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor...

Lands' End Announces Fourth Quarter and Fiscal 2022

DODGEVILLE, Wis., March 02, 2023 (GLOBE NEWSWIRE) -- Lands' End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Thursday,...

Cerevel Therapeutics to Present at the 43rd Annual Cowen

CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain...

LegalZoom to Participate in Upcoming Investor Conferences

GLENDALE, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- LegalZoom.com, Inc. (Nasdaq: LZ) today announced its participation in the JMP Securities Technology...